Evidence map›Paper›PMID 41888112›Full record

ArticleCell death & disease2026

CHK1 is an integral regulator of DNA replication in human cells.

Siting Li, Dandan Zhu, Mengfan Tang, Min Huang, Xu Feng, Litong Nie, Huimin Zhang, Ling Yin, Sarah Keast, Chang Yang and 2 more

Abstract read
In one paragraph

Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Siting Li *Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dandan Zhu *Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0003-4609-1238
Mengfan TangDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Min HuangDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Xu FengDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Litong NieDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-0326-4517
Huimin ZhangDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ling YinDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sarah KeastDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chang YangDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Tiantian MaDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Junjie ChenDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jchen8@mdanderson.org.ORCID http://orcid.org/0000-0002-1493-2189

Funding

U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) CA274234, CA275712, CA278758
6 · The paper itself

Abstract

CHK1, a key serine/threonine kinase, is essential for cell cycle progression and genome maintenance in response to DNA damage and/or replication stress. However, its functions during normal DNA replication remain to be defined. Here, we employed the dTAG system to achieve rapid and selective CHK1 depletion in cells and examined the consequences of its acute loss. CHK1 degradation led to rapid cell death, with significant loss of viability within 16 h and complete lethality by 48 h, indicating critical roles of CHK1 during normal DNA replication. Rescue experiments demonstrated that only full-length, catalytically active CHK1 could restore cell survival, emphasizing the essential role of its kinase function and ATR-dependent phosphorylation. CHK1 depletion triggered extensive DNA damage, as evidenced by increased γH2AX and RPA2 phosphorylation, and caused S-phase arrest, replication fork collapse, and failure to enter mitosis. Interestingly, cells arrested at the G1/S boundary, which do not undergo DNA replication, were still sensitive to CHK1 depletion. These data reveal a critical role of CHK1 in suppressing replication fork progression even in the absence of DNA replication. Thus, our results highlight CHK1's indispensable role in the management of replication fork stability and cell cycle progression, providing a refined mechanistic understanding of its function during normal cell proliferation.

Indexed as

DNA ReplicationProtein KinasesAtaxia Telangiectasia Mutated ProteinsCell SurvivalCheckpoint Kinase 1DNA DamageHistonesHumansPhosphorylationReplication Protein AAtaxia Telangiectasia Mutated ProteinsCheckpoint Kinase 1CHEK1 protein, humanH2AX protein, humanHistonesProtein KinasesReplication Protein ARPA2 protein, human

Identifiers

PMID41888112
PMCPMC13039271

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.